Implementation of National Institute for Health and Care Excellence (NICE) Technology Assessment Guidance (TAG) 557: pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer (NSCLC) – successes and challenges in a cancer unit